Not known Factual Statements About conolidine
Andy Chevigné and his team, RTI-5152-12 is postulated to raise the amounts of opioid peptides that bind to classical opioid receptors in the brain, resulting in heightened painkilling action. The LIH-RTI investigation teams established a collaboration settlement and filed a joint patent software in December 2020.Conolidine CONOCB2™, which has be